Hansoh Pharmaceutical Group Company Limited
3692
Hisse Senetlerindeki Sıralama
#920
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Hisse Fiyatı
$4.36
Piyasa Değeri
$26.46B
Değişim (1 gün)
-0.76%
Değişim (1 yıl)
-5.51%
Ülke
CN
Ticaret Hansoh Pharmaceutical Group Company Limited (3692)
Kategori
Healthcare
Hansoh Pharmaceutical Group Company Limited (3692) için tedavüldeki hisse sayısı
June 2026 itibarıyla tedavüldeki hisse sayısı: 6.06B
Hansoh Pharmaceutical Group Company Limited şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 6.06B'dir. December 2023 sonunda şirketin 6.27B tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
Hansoh Pharmaceutical Group Company Limited (3692) için 2016 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
| Yıl | Tedavüldeki Hisse Sayısı | Değiştir |
|---|---|---|
| 2026 (TTM) | 6.06B | 2.13% |
| 2024 | 5.93B | -5.45% |
| 2023 | 6.27B | 6.02% |
| 2022 | 5.92B | -0.09% |
| 2021 | 5.92B | 0.76% |
| 2020 | 5.88B | 7.28% |
| 2019 | 5.48B | -4.00% |
| 2018 | 5.71B | 0.00% |
| 2017 | 5.71B | 0.00% |
| 2016 | 5.71B | 0.00% |
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
| Şirket | Tedavüldeki Hisse Sayısı | Fark | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | -60.39% |
IN
|
